MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | - | - | ₹1.45 Cr | ₹1.45 Cr | ₹20 Cr |
What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2025 | - |
Mar2024 | - |
Mar2023 | ₹1.45 Cr |
Mar2022 | ₹1.45 Cr |
Mar2021 | ₹20 Cr |
How is Contingent Liabilities of MARKSANS PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | - | 0 | |
Mar2024 | - | -100.00 | |
Mar2023 | ₹1.45 Cr | 0.00 | |
Mar2022 | ₹1.45 Cr | -92.68 | |
Mar2021 | ₹20 Cr | - |
Compare Contingent Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,752.2 Cr | -8.4% | -2.3% | 29.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -8.4% |
-2.3% |
29.2% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses